Company Analysis
Sign in

CervoMed Inc. (CRVO)

Nasdaq: CRVO · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 1998
Full chart Alerts Compare
Grade4.3
◀ Past 2.7● Present 4.4▶ Future 5.1
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Filings

451 filings since 2017 beside 175 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
6471466779756365
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Oct 29, 2025.SEC letters: 7 in the last 36 months, the newest Sep 24, 2025.
Insider forms 175

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 6, 2026 10-Q Quarterly report Sep 30, 2026
Oct 29, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Oct 14, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 13, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Oct 12, 2026
Oct 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 28, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 10, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2026 S-8 Employee stock plan registration
Aug 7, 2026 10-Q Quarterly report Jun 30, 2026
Aug 4, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jul 14, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jul 10, 2026 EFFECT Registration effective
Jul 10, 2026 424B3 Shelf offering
Jul 9, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jul 8, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 6, 2026 S-3 Shelf registration
Jun 26, 2026 SCHEDULE 13G Large holder notice
Jun 22, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jun 22, 2026 424B5 Shelf offering
Jun 22, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Jun 18, 2026
Jun 18, 2026 8-K items 8.01, 9.01 Other event · Current report Jun 16, 2026
Jun 15, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 15, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 10, 2026 8-K items 1.01, 3.02, 7.01, 8.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report Jun 9, 2026
Jun 9, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 8, 2026
May 18, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEF 14A Proxy statement Jun 8, 2026
Apr 22, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Apr 7, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 7, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 23, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
40 of 451 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CRVO · research, not advice